|
With the greater
use of information technology and computerisation, electronic records
and signatures are having a significant effect on the pharmaceutical manufacturing
industry.
FDA rule 21 CFR Part
11 details procedures and regulations for specific control and use of
electronic records within a strict administrative protocol.
Keeping pace with
change, Optimal has developed and installed a number of systems that implement
the 21CFR Part 11 requirements in both new and legacy systems.
If you expect your
process procedures to fall within the scope of the new code, an early
discussion with Optimal could provide you with a cost effective practical
solution.
|